Table 3.
Implementation of clinical practice guidelines for pregnant patients with primary immune thrombocytopenia who delivered at the University of Oklahoma Health hospital system between 2011 and 2020.
Implementation of Guidelines | ||
---|---|---|
Characteristic | No N (%) |
Yes N (%) |
During Pregnancy | “Adherent” to strong recommendation | |
Severe thrombocytopenia (platelet count <30 × 109/L) |
0 | 13/13 (100%) |
Moderate thrombocytopenia (platelet count ≥30 × 109/L and ≤99 × 109/L) |
18/53 (36%) |
34/53 (64%) |
Mild thrombocytopenia (platelet count ≥100 × 109/L and <150 × 109/L) |
0 | 11/11 (100%) |
During and For Delivery | “Consistent with” the conditional guidelines | |
Cesarean delivery | 0 | 27/27 (100%) |
Epidural/spinal anesthesia | 8/21 (38%) | 13/21 (62%) |